Dermatofibroma classification: Difference between revisions
Homa Najafi (talk | contribs) |
m Bot: Removing from Primary care |
||
(One intermediate revision by one other user not shown) | |||
Line 15: | Line 15: | ||
| pages = 529–539 | | pages = 529–539 | ||
| year = 2000 | | year = 2000 | ||
| pmid = 10849095 | | pmid = 10849095 | ||
}}</ref><ref name="JonesCerio2006">{{cite journal|last1=Jones|first1=E. Wilson|last2=Cerio|first2=R.|last3=Smith|first3=N.P.|title=Epithelioid cell histiocytoma: a new entity|journal=British Journal of Dermatology|volume=120|issue=2|year=2006|pages=185–195|issn=00070963|doi=10.1111/j.1365-2133.1989.tb07782.x}}</ref><ref name="ZelgerZelger1996">{{cite journal|last1=Zelger|first1=B W|last2=Zelger|first2=B G|last3=Steiner|first3=H|last4=Ofner|first4=D|title=Aneurysmal and haemangiopericytoma-like fibrous histiocytoma.|journal=Journal of Clinical Pathology|volume=49|issue=4|year=1996|pages=313–318|issn=0021-9746|doi=10.1136/jcp.49.4.313}}</ref><ref>{{Cite journal | }}</ref><ref name="JonesCerio2006">{{cite journal|last1=Jones|first1=E. Wilson|last2=Cerio|first2=R.|last3=Smith|first3=N.P.|title=Epithelioid cell histiocytoma: a new entity|journal=British Journal of Dermatology|volume=120|issue=2|year=2006|pages=185–195|issn=00070963|doi=10.1111/j.1365-2133.1989.tb07782.x}}</ref><ref name="ZelgerZelger1996">{{cite journal|last1=Zelger|first1=B W|last2=Zelger|first2=B G|last3=Steiner|first3=H|last4=Ofner|first4=D|title=Aneurysmal and haemangiopericytoma-like fibrous histiocytoma.|journal=Journal of Clinical Pathology|volume=49|issue=4|year=1996|pages=313–318|issn=0021-9746|doi=10.1136/jcp.49.4.313}}</ref><ref>{{Cite journal | ||
Line 25: | Line 24: | ||
| pages = 551–557 | | pages = 551–557 | ||
| year = 1996 | | year = 1996 | ||
| pmid = 9001986 | | pmid = 9001986 | ||
}}</ref><ref>{{Cite journal | }}</ref><ref>{{Cite journal | ||
Line 35: | Line 33: | ||
| pages = 357–364 | | pages = 357–364 | ||
| year = 1999 | | year = 1999 | ||
| pmid = 10231403 | | pmid = 10231403 | ||
}}</ref><ref>{{Cite journal | }}</ref><ref>{{Cite journal | ||
Line 45: | Line 42: | ||
| pages = 1–7 | | pages = 1–7 | ||
| year = 1999 | | year = 1999 | ||
| pmid = 10027517 | | pmid = 10027517 | ||
}}</ref><ref>{{Cite journal | }}</ref><ref>{{Cite journal | ||
Line 55: | Line 51: | ||
| pages = 668–676 | | pages = 668–676 | ||
| year = 1994 | | year = 1994 | ||
| pmid = 8017561 | | pmid = 8017561 | ||
}}</ref><ref>{{Cite journal | }}</ref><ref>{{Cite journal | ||
Line 65: | Line 60: | ||
| pages = 483–491 | | pages = 483–491 | ||
| year = 1996 | | year = 1996 | ||
| pmid = 8604817 | | pmid = 8604817 | ||
}}</ref><ref>{{Cite journal | }}</ref><ref>{{Cite journal | ||
Line 75: | Line 69: | ||
| pages = 562–565 | | pages = 562–565 | ||
| year = 1996 | | year = 1996 | ||
| pmid = 9001988 | | pmid = 9001988 | ||
}}</ref> | }}</ref> | ||
Line 135: | Line 128: | ||
6. Combined dermatofibroma}} | 6. Combined dermatofibroma}} | ||
{| | {| | ||
==References== | ==References== | ||
Line 145: | Line 136: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] |
Latest revision as of 21:17, 29 July 2020
Dermatofibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Dermatofibroma classification On the Web |
American Roentgen Ray Society Images of Dermatofibroma classification |
Risk calculators and risk factors for Dermatofibroma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
Dermatofibroma may be classified according to histopathology into three groups, variants that are prominent in architectural (low-power) properties, variants that are prominent in cytologic or stromal (high-power) properties, and variants that have architectural (low) and cytological or stromal (high-power) properties.
Classification
Dermatofibroma may be classified according to histopathology into three groups:[1][2][3][4][5][6][7][8][9]
- Variants that are prominent in architectural (low-power) properties
- Variants that are prominent in cytologic or stromal (high-power) properties
- Variants that have architectural (low) and cytological or stromal (high-power) properties
Histopathology varient of dermatofibroma | |||||||||||||||||||||||||||||||||||||
Variants that are prominent in architectural (low-power) properties | Variants that are prominent in cytologic or stromal (high-power) properties | Variants that have architectural (low) and cytological or stromal (high-power) properties | |||||||||||||||||||||||||||||||||||
1. Deep penetrating dermatofibroma
2. Atrophic dermatofibroma 3. Aneurysmal fibrous histiocytoma 4. Haemangiopericytoma-like fibrous histiocytoma 5. Palisading cutaneous fibrous histiocytoma 6. Lichenoid, erosive, & ulcerated dermatofibroma 7. Plaque-like dermal fibromatosis, dermatofibroma | 1. Clear cell dermatofibroma
2. Granular cell dermatofibroma 3. Myofibroblastic dermatofibroma 4. Sclerotic dermatofibroma 5. Keloidal dermatofibroma 6. Atypical/pseudosarcomatous fibrous histiocytoma, dermatofibroma with monster cells 7. Hemosiderrhotic dermatofibroma 8. Cholesterotic/lipidized dermatofibroma 9. Myxoid dermatofibroma 10. Ossifying dermatofibroma 11. Pseudolymphomatous dermatofibroma 12. Dermatofibroma with diffuse eosinophilic infiltrate | 1. Epithelioid cell histiocytoma
2. Cellular benign fibrous histiocytoma 3. Smooth muscle proliferation in dermatofibroma 4. Multinucleate cell angiohistiocytoma 5. Cellular neurothekeoma 6. Combined dermatofibroma | |||||||||||||||||||||||||||||||||||
References
- ↑ B. G. Zelger, A. Sidoroff & B. Zelger (2000). "Combined dermatofibroma: co-existence of two or more variant patterns in a single lesion". Histopathology. 36 (6): 529–539. PMID 10849095.
- ↑ Jones, E. Wilson; Cerio, R.; Smith, N.P. (2006). "Epithelioid cell histiocytoma: a new entity". British Journal of Dermatology. 120 (2): 185–195. doi:10.1111/j.1365-2133.1989.tb07782.x. ISSN 0007-0963.
- ↑ Zelger, B W; Zelger, B G; Steiner, H; Ofner, D (1996). "Aneurysmal and haemangiopericytoma-like fibrous histiocytoma". Journal of Clinical Pathology. 49 (4): 313–318. doi:10.1136/jcp.49.4.313. ISSN 0021-9746.
- ↑ J. S. Silverman & S. Brustein (1996). "Myxoid dermatofibrohistiocytoma: an indolent post-traumatic tumor composed of CD34+ epithelioid and dendritic cells and factor XIIIa+ dendrophages". Journal of cutaneous pathology. 23 (6): 551–557. PMID 9001986.
- ↑ B. G. Zelger, E. Calonje & B. Zelger (1999). "Myxoid dermatofibroma". Histopathology. 34 (4): 357–364. PMID 10231403.
- ↑ E. J. Glusac & J. M. McNiff (1999). "Epithelioid cell histiocytoma: a simulant of vascular and melanocytic neoplasms". The American Journal of dermatopathology. 21 (1): 1–7. PMID 10027517.
- ↑ E. Calonje, T. Mentzel & C. D. Fletcher (1994). "Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence". The American journal of surgical pathology. 18 (7): 668–676. PMID 8017561.
- ↑ B. W. Zelger, H. Steiner & H. Kutzner (1996). "Clear cell dermatofibroma. Case report of an unusual fibrohistiocytic lesion". The American journal of surgical pathology. 20 (4): 483–491. PMID 8604817.
- ↑ J. F. Val-Bernal & C. Mira (1996). "Dermatofibroma with granular cells". Journal of cutaneous pathology. 23 (6): 562–565. PMID 9001988.